Scott Platshon appointed to Zymeworks board; EcoR1 Capital partner joins

Zymeworks Inc.

Appointed as Class III director effective Feb. 22, 2024; term expires at 2024 annual meeting.
Appointment follows EcoR1's $50M investment in Dec 2023 (5.09M pre-funded warrants at $9.83/share).
Platshon waived cash and equity compensation under director compensation policy.
EcoR1's board nomination right terminates upon appointment or Jan. 1, 2026, whichever earliest.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Scott Platshon

director

ZYME · Zymeworks Inc.

Effective: 2024-02-22
Filed: February 22, 2024, 6:59 PM ET

appointed Mr. Scott Platshon, Partner of EcoR1 (as defined below), as a director of the Company, effective as of February 22, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Scott Platshon was appointed as director at Zymeworks Inc..

Action: appointed
Role: director

Exact text from the filing

appointed Mr. Scott Platshon, Partner of EcoR1 (as defined below), as a director of the Company, effective as of February 22, 2024.

View on SEC.gov

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-042846

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.